CDH2 and esophageal squamous cell carcinoma: Additionally, SC79 pretreatment notably reversed Bru-induced downregulation of N-cadherin and Vimentin gene expressions and upregulation of E-cadherin gene expression in both ESCC cell lines (p < 0.05, p < 0.01, Figure 7C).